secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2026-06-17T10:05:23+00:00
Accession:  0001077183-26-000031
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics prices $275M convertible notes due 2032; to repurchase $276M of existing notes
--------------------------------------------------------------------------------

- $275M principal of 0.75% convertible notes due 2032; initial purchasers have option for additional $41.25M.
- Initial conversion price ~$14.16/share, a 35% premium to $10.49 closing price on June 16, 2026.
- Net proceeds ~$266.15M; ~$25M used for capped call transactions (cap price $20.98/share).
- Concurrently repurchasing $276M of existing 0.25% convertible notes due 2028 for ~$263.19M.
- Also plans to repurchase up to $25M of common stock from certain note purchasers; offering expected to close June 22, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718326000031/0001077183-26-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718326000031/neo-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001077183-26-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer